Psychiatric side effects were tracked closely, especially: Depression Anxiety Suicidal ideation Regulatory agencies reviewed these outcomes carefully and did not find a consistent signal suggesting GLP-1 medications directly cause anger or aggression
has received honoraria for lectures from AstraZeneca and Novo Nordisk
has segmented the GLP-1 receptor agonist market Product Application Route of Administration Distribution Channel Regional
A recently published ACC scientific statement highlighted major findings showing cardiovascular benefits from both semaglutide (GLP1 RA) and tirzepatide (GLP1/GIP RA)including improvements in cardiac structure and functiondemonstrating lower rates of heart failure and major cardiovascular events
Licensed healthcare professionals evaluate each patient to determine eligibility and create personalized treatment plans focused on safe, sustainable weight loss and metabolic health
Shima Hadidchi MDs practice with obesity, high blood pressure, type 2 diabetes, or high cholesterol